NCT05693831View on ClinicalTrials.gov

myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

RecruitingOBSERVATIONAL

Enrollment

730

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

December 1, 2025

Conditions

CancerRelapsed CancerRefractory Cancer

Interventions

OTHER

Cellworks Report

Survey physicians and molecular tumor board perspectives of the benefit of Cellworks Singula™ and Ventura™ reports in facilitating treatment decisions in pan-cancer patients.

Trial Locations (1)

57108

RECRUITING

Avera Cancer Institute, Sioux Falls

All Listed Sponsors

lead

Cellworks Group Inc.

INDUSTRY